SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
Abstract Fibrosis and organ failure is a common endpoint for many chronic liver diseases. Much is known about the upstream inflammatory mechanisms provoking fibrosis and downstream potential for tissue remodeling. However, less is known about the transcriptional regulation in vivo governing fibrotic...
Saved in:
| Main Authors: | Varinder S Athwal, James Pritchett, Jessica Llewellyn, Katherine Martin, Elizabeth Camacho, Sayyid MA Raza, Alexander Phythian‐Adams, Lindsay J Birchall, Aoibheann F Mullan, Kim Su, Laurence Pearmain, Grace Dolman, Abed M Zaitoun, Scott L Friedman, Andrew MacDonald, William L Irving, Indra N Guha, Neil A Hanley, Karen Piper Hanley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2017-11-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201707860 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The SOX18-OTUB1-YAP1 axis: a new endometriosis target
by: Ying Feng, et al.
Published: (2025-06-01) -
Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.
by: James Pritchett, et al.
Published: (2014-01-01) -
The role of SOX transcription factors in prostate cancer: Focusing on SOX2
by: Guotu Du, et al.
Published: (2025-11-01) -
Immunohistochemical investigation of SOX2 expression in Iraqi patients with high-grade glioma
by: Hadeer Hashim Shams Uldeen, et al.
Published: (2024-09-01) -
Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling
by: Dan Wang, et al.
Published: (2025-06-01)